Filter posts

Industry Growth Factor: Biologics

Last week, EvaluatePharma released their updated sales and R&D outlook for the drug industry in their …

Spotlight on China

The 20th annual BIO International Convention is wrapping up in Chicago. Experts and leaders from …

Despite Low Funding, Biotech Productivity Remains High In 2013

At the 2013 BIO CEO & Investor Conference, John Milligan, President and COO of Gilead …

Data Exclusivity Protects Innovators and Assures Investors

Biotechnology companies must have some certainty that they can protect their investment in the development …

Reviewing the drug class of 2011

The drug class of 2011 was larger than the past few graduating classes. We count …

Breast Cancer and Biotechnology: Bigger Than Pink

By David Welch, President/Senior Producer at M2 MultiMedia It had been five years since I …

Data Protection, Trans Pacific Partnership, and the US-Jordan FTA (Post 2 of 2)

This post is a continuation of a previous post: Data Protection, the Trans Pacific Partnership, …

Huffington Post: Data Exclusivity: Getting the Balance Right

Huffington Post: Data Exclusivity: Getting the Balance Right      A great article on the downsides …

2011 BIO International Convention Super Sessions

2011 BIO International Convention Super Sessions Focus on State of the Industry C-Level speakers lead …